These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

676 related items for PubMed ID: 26628405

  • 61. Identification of differentially expressed genes regulated by molecular signature in breast cancer-associated fibroblasts by bioinformatics analysis.
    Vastrad B, Vastrad C, Tengli A, Iliger S.
    Arch Gynecol Obstet; 2018 Jan; 297(1):161-183. PubMed ID: 29063236
    [Abstract] [Full Text] [Related]

  • 62. Expression profile analysis reveals putative prostate cancer-related microRNAs.
    Song H, Liu Y, Pan J, Zhao ST.
    Genet Mol Res; 2013 Oct 24; 12(4):4934-43. PubMed ID: 24301753
    [Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66. Combined identification of three miRNAs in serum as effective diagnostic biomarkers for HNSCC.
    Liu C, Yu Z, Huang S, Zhao Q, Sun Z, Fletcher C, Jiang Y, Zhang D.
    EBioMedicine; 2019 Dec 24; 50():135-143. PubMed ID: 31780396
    [Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69. Comparison of Transcriptome Between Type 2 Diabetes Mellitus and Impaired Fasting Glucose.
    Cui Y, Chen W, Chi J, Wang L.
    Med Sci Monit; 2016 Dec 01; 22():4699-4706. PubMed ID: 27906902
    [Abstract] [Full Text] [Related]

  • 70. miRNA expression patterns in chemoresistant breast cancer tissues.
    Lv J, Xia K, Xu P, Sun E, Ma J, Gao S, Zhou Q, Zhang M, Wang F, Chen F, Zhou P, Fu Z, Xie H.
    Biomed Pharmacother; 2014 Oct 01; 68(8):935-42. PubMed ID: 25451164
    [Abstract] [Full Text] [Related]

  • 71. Epigenetic regulation on the gene expression signature in esophagus adenocarcinoma.
    Xi T, Zhang G.
    Pathol Res Pract; 2017 Feb 01; 213(2):83-88. PubMed ID: 28049580
    [Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75. Novel miRNAs as potential biomarkers in stage II colon cancer: microarray analysis.
    Gungormez C, Gumushan Aktas H, Dilsiz N, Borazan E.
    Mol Biol Rep; 2019 Aug 01; 46(4):4175-4183. PubMed ID: 31123908
    [Abstract] [Full Text] [Related]

  • 76. An Integrated miRNA-lncRNA Signature Predicts the Survival of Stage II Colon Cancer.
    Wang XJ, Zeng B, Lin S, Chen M, Chi P.
    Ann Clin Lab Sci; 2019 Nov 01; 49(6):730-739. PubMed ID: 31882423
    [Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78. A novel three‑miRNA signature predicts survival in cholangiocarcinoma based on RNA‑Seq data.
    Cao J, Sun L, Li J, Zhou C, Cheng L, Chen K, Yan B, Qian W, Ma Q, Duan W.
    Oncol Rep; 2018 Sep 01; 40(3):1422-1434. PubMed ID: 29956786
    [Abstract] [Full Text] [Related]

  • 79. The expression of miR-375 in prostate cancer: A study based on GEO, TCGA data and bioinformatics analysis.
    He S, Shi J, Mao J, Luo X, Liu W, Liu R, Yang F.
    Pathol Res Pract; 2019 Jun 01; 215(6):152375. PubMed ID: 30879885
    [Abstract] [Full Text] [Related]

  • 80. MicroRNA hsa-mir-3923 serves as a diagnostic and prognostic biomarker for gastric carcinoma.
    Yang X, Zhang Z, Zhang L, Zhou L.
    Sci Rep; 2020 Mar 13; 10(1):4672. PubMed ID: 32170105
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.